Thomas Eigentler
Impact in
- Oncology top 0.2%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 193
- Cutaneous Melanoma Detection and Management 128
- Cancer Immunotherapy and Biomarkers 45
- CAR-T cell therapy research 44
- Polyomavirus and related diseases 8
-
- Melanoma and MAPK Pathways 57
- Co-authors
- Claus Garbe (160 shared papers)Ulrike Leiter (66 shared papers)Benjamin Weide (36 shared papers)Friedegund Meier (51 shared papers)Ralf Gutzmer (36 shared papers)Axel Hauschild (24 shared papers)Peter Radny (12 shared papers)Helmut Breuninger (17 shared papers)
- Journals
- Journal of Clinical Oncology (33 papers)JDDG Journal der Deutschen Dermatologischen Gesellschaft (28 papers)Annals of Oncology (15 papers)European Journal of Cancer (13 papers)Melanoma Research (10 papers)
- Partner nations
- GermanyUnited StatesAustralia
In The Last Decade
Thomas Eigentler
258 papers receiving 9.5k citations
Thomas Eigentler's Hit Papers
Peers
Comparison fields: 5 of 154
- Oncology 5.8k
- Immunology 2.1k
- Dermatology 794
- Molecular Biology 3.0k
- Epidemiology 1.2k
Countries citing papers authored by Thomas Eigentler
This map shows the geographic impact of Thomas Eigentler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Eigentler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Eigentler more than expected).
Fields of papers citing papers by Thomas Eigentler
This network shows the impact of papers produced by Thomas Eigentler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Eigentler. The network helps show where Thomas Eigentler may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Eigentler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 272 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epidemiology of Skin Cancer Hit paper breakdown → | 2014 | 469 |
| 2 | Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2020 | 460 |
| 3 | 2011 | 453 | |
| 4 | 2016 | 320 | |
| 5 | 2009 | 320 | |
| 6 | 2019 | 259 | |
| 7 | 2003 | 246 | |
| 8 | 2017 | 244 | |
| 9 | 2008 | 220 | |
| 10 | 2008 | 199 | |
| 11 | 2007 | 178 | |
| 12 | 2019 | 163 | |
| 13 | 2003 | 152 | |
| 14 | 2007 | 146 | |
| 15 | 2017 | 146 | |
| 16 | 2019 | 137 | |
| 17 | 2010 | 129 | |
| 18 | 2011 | 126 | |
| 19 | 2010 | 118 | |
| 20 | 2017 | 114 |
About Thomas Eigentler
Thomas Eigentler is a scholar working on Oncology, Molecular Biology, Immunology, Epidemiology and Dermatology, having authored 272 papers that have together received 9.7k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (128 papers), Melanoma and MAPK Pathways (57 papers), Cancer Immunotherapy and Biomarkers (45 papers), CAR-T cell therapy research (44 papers), Immunotherapy and Immune Responses (41 papers), Nonmelanoma Skin Cancer Studies (33 papers), Cutaneous lymphoproliferative disorders research (19 papers) and Polyomavirus and related diseases (8 papers). The work is most often cited by research in Oncology (5.8k citations), Immunology (2.1k citations), Dermatology (794 citations), Molecular Biology (3.0k citations) and Epidemiology (1.2k citations). Thomas Eigentler has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Claus Garbe, Ulrike Leiter, Benjamin Weide, Friedegund Meier, Ralf Gutzmer, Axel Hauschild, Peter Radny, Helmut Breuninger, Annette Pflugfelder and Andrea Forschner. Their work appears in journals such as Journal of Clinical Oncology, JDDG Journal der Deutschen Dermatologischen Gesellschaft, Annals of Oncology, European Journal of Cancer and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.